Research report

United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023

Format : Pdf

Publish Date: 19th February 2018

Pages: 140

The report titled “United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023” examines the market dynamics, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for NIPT test in United States. The research includes historic data from 2015 to 2017 and forecasts until 2023.

The report titled “United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023” examines the market dynamics, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for NIPT test in United States. The research includes historic data from 2015 to 2017 and forecasts until 2023.

Long–term Growth Projection:

•    United States is anticipated to be the most attractive market in the
      Non-Invasive Prenatal Testing(NIPT) industry
•    United States Non-Invasive Prenatal Testing(NIPT) is expected to
      register a faster value growth during 2018 - 2023
•    The Potential United States Non-Invasive Prenatal Testing(NIPT) Market
      is set to cross USD 2.5 Billion by 2023
•    MaterniT21 PLUS, Harmony, Verifi, Panorama are the popular test in the
      United States Non-Invasive Prenatal Testing(NIPT) Market

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2023. The report also includes assessment of comparative test analysis by companies. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT test market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.

The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Illumina, Natera, Quest Diagnostics, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche)

Major and Promising NIPT test covered in the report are as follows:

MaterniT21 PLUS, VisibiliT, MaterniT21 GENOME, Harmony, Verifi, Panorama, Vistara and QNatal Advanced

The Latest Industry Data Included in this Report:

•    Actual NIPT Test Volume & Market Revenue (2015 - 2023)
•    Average Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
•    High Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
•    Potential NIPT Test Volume & Market Revenue (2015 - 2023)
•    Average Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
•    High Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
•    NIPT Test Market - Reimbursement & Regulation System
•    NIPT Test Implementation in High–Income Countries
•    Comparative Test Analysis – By Companies
•    Major Deals in Non–Invasive Prenatal Testing Market
•    Key Companies Analysis
•    Key Market Drivers and Inhibitors of the United States NIPT Test Market

1.    Executive Summary


2.    Market Size & Analysis: United States Non–Invasive Prenatal Testing (2015 – 2023)


2.1    Overall Actual NIPT Test Volume & Forecast (2015 - 2023)
2.1.1    Average Risk Actual NIPT Test Volume
2.1.2    High Risk Actual NIPT Test Volume


2.2    Overall Actual NIPT Test Market Revenue & Forecast (2015 -  2023)
2.2.1    Average Risk Actual NIPT Test Market Revenue
2.2.2    High Risk Actual NIPT Test Market Revenue


3.    Market Opportunity Assessment: United States Non–Invasive Prenatal Testing (2015 – 2023)


3.1    Overall Potential NIPT Test Volume & Forecast (2015 - 2023)

3.1.1    Average Risk Potential NIPT Test Volume
3.1.2    High Risk Potential NIPT Test Volume


3.2    Overall Potential NIPT Test Market Revenue & Forecast (2015 -  2023)
3.2.1    Average Risk Potential NIPT Test Market Revenue
3.2.2    High Risk Potential NIPT Test Market Revenue


4.    Key Drivers and Inhibitors of the United States NIPT Test Market


4.1    Market Drivers
4.2    Inhibitors


5.    Non–Invasive Prenatal Testing Competitive Analysis: By Company


6.    United States NIPT Test Market: Reimbursement & Regulation System


6.1    Reimbursement System
6.2    Regulation System


7.    Major Deals in Non–Invasive Prenatal Testing Market


7.1    Collaboration Deals
7.2    Venture Capital Investment
7.3    Merger and Acquisition
7.4    Exclusive Agreement
7.5    Licensing Agreement
7.6    Distribution Agreement
7.7    Partnership Deals


8.    Non–Invasive Prenatal Testing Implementation – High–Income Countries


8.1.1    Clinical Issues
8.1.2    Ethical Issues
8.1.3    Legal and Regulatory Issues


9.    Key Companies Analysis


9.1    Sequenom Laboratories (LabCorp)
9.1.1    Business Overview
9.1.2    NIPT Test Portfolio
9.1.3    NIPT Test Analysis (Volume and Value)
9.1.3.1    Overall NIPT Test Volume & Forecast
9.1.3.2    Overall NIPT Test Market Revenue & Forecast
9.1.4    Sequenom Laboratories – International Distributors
9.1.5    NIPT Test - Latest Development & Trends


9.2    Ariosa Diagnostics (Roche)
9.2.1    Business Overview
9.2.2    NIPT Test Portfolio
9.2.3    NIPT Test Analysis (Volume and Value)
9.2.3.1    Overall NIPT Test Volume & Forecast
9.2.3.2    Overall NIPT Test Market Revenue & Forecast
9.2.4    NIPT Test - Latest Development & Trends


9.3    Illumina
9.3.1    Business Overview
9.3.2    NIPT Test Portfolio
9.3.3    NIPT Test Analysis (Volume and Value)
9.3.3.1    Overall NIPT Test Volume & Forecast
9.3.3.2    Overall NIPT Test Market Revenue & Forecast
9.3.4    NIPT Test - Latest Development & Trends


9.4    Natera
9.4.1    Business Overview
9.4.2    NIPT Test Portfolio
9.4.3    NIPT Test Analysis (Volume and Value)
9.4.3.1    Overall NIPT Test Volume & Forecast
9.4.3.2    Overall NIPT Test Market Revenue & Forecast
9.4.4    NIPT Test - Latest Development & Trends


9.5    Quest Diagnostics
9.5.1    Business Overview
9.5.2    NIPT Test Portfolio
9.5.3    NIPT Test - Latest Development & Trends

List of Tables

Table 3 1: Maternal Age at Delivery and Risk of Down Syndrome
Table 6 1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 4 1: NIPT Test CMS Price(US$),2017
Table 6 2: Non–Invasive Prenatal Testing – Collaboration Deals, 2007 – 2018
Table 6 3: Non–Invasive Prenatal Testing – Venture Capital Investment, 2011 – 2015
Table 6 4: Non–Invasive Prenatal Testing – Merger & Acquisition, 2013 – 2016
Table 6 5: Non–Invasive Prenatal Testing – Exclusive Agreement, 2008 – 2016
Table 6 6: Non–Invasive Prenatal Testing – Licensing Agreement, 2007 – 2015
Table 6 7: Non–Invasive Prenatal Testing – Distribution Agreement, 2012 – 2014
Table 6 8: Non–Invasive Prenatal Testing – Partnership Deals, 2013 – 2015


List of Figures

Figure 2 1: United States – Actual NIPT Test Volume(Thousand),2015 – 2017
Figure 2 2: United States – Forecast for Actual NIPT Test Volume(Thousand),2018 – 2023
Figure 2 3: United States – Average Risk Actual NIPT Test Volume(Thousand),2015 – 2017
Figure 2 4: United States – Forecast for Average Risk Actual NIPT Test Volume(Thousand),2018 – 2023
Figure 2 5: United States – High Risk Actual NIPT Test Volume(Thousand),2015 – 2017
Figure 2 6: United States – Forecast for High Risk Actual NIPT Test Volume(Thousand),2018 – 2023
Figure 2 13: United States – Actual NIPT Test Market Revenue (Million US$),2015 – 2017
Figure 2 14: United States – Forecast for Actual NIPT Test Market Revenue (Million US$),2018 – 2023
Figure 2 15: United States – Average Risk Actual NIPT Test Market Revenue (Million US$),2015 – 2017
Figure 2 16: United States – Forecast for Average Risk Actual NIPT Test Market Revenue (Million US$),2018 – 2023
Figure 2 17: United States – High Risk Actual NIPT Test Market Revenue (Million US$),2015 – 2017
Figure 2 18: United States – Forecast for High Risk Actual NIPT Test Market Revenue (Million US$),2018 – 2023
Figure 2 7: United States – Potential NIPT Test Volume(Thousand),2015 – 2017
Figure 2 8: United States – Forecast for Potential NIPT Test Volume(Thousand),2018 – 2023
Figure 2 9: United States – Average Risk Potential NIPT Test Volume(Thousand),2015 – 2017
Figure 2 10: United States – Forecast for Average Risk Potential NIPT Test Volume(Thousand),2018 – 2023
Figure 2 11: United States – High Risk Potential NIPT Test Volume(Thousand),2015 – 2017
Figure 2 12: United States – Forecast for High Risk Potential NIPT Test Volume(Thousand),2018 – 2023
Figure 2 19: United States – Potential NIPT Test Market Revenue (Million US$),2015 – 2017
Figure 2 20: United States – Forecast for Potential NIPT Test Market Revenue (Million US$),2018 – 2023
Figure 2 21: United States – Average Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2017
Figure 2 22: United States – Forecast for Average Risk Potential NIPT Test Market Revenue (Million US$),2018 – 2023
Figure 2 23: United States – High Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2017
Figure 2 24: United States – Forecast for High Risk Potential NIPT Test Market Revenue (Million US$),2018 – 2023
Figure 7 1: Sequenom – Overall NIPT Test Volume (Thousand), 2011 – 2017
Figure 7 2: Sequenom – Forecast for Overall NIPT Test Volume (Thousand), 2018 – 2023
Figure 7 3: Sequenom - Overall NIPT Test Market Revenue (Million US$),2011 – 2016
Figure 7 4: Sequenom – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 7 5: Ariosa Diagnostics – Overall NIPT Test Volume (Thousand), 2012 – 2017
Figure 7 6: Ariosa Diagnostics – Forecast for Overall NIPT Test Volume (Thousand), 2018 – 2023
Figure 7 7: Ariosa Diagnostics - Overall NIPT Test Market Revenue (Million US$),2012 – 2017
Figure 7 8: Ariosa Diagnostics – Forecast for Overall NIPT Test Market Revenue (Million US$),2018 – 2023
Figure 7 9: Illumina – Overall NIPT Test Volume (Thousand), 2012 – 2017
Figure 7 10: Illumina – Forecast for Overall NIPT Test Volume (Thousand), 2018 – 2023
Figure 7 11: Illumina - Overall NIPT Test Market Revenue (Million US$),2012 – 2017
Figure 7 12: Illumina – Forecast for Overall NIPT Test Market Revenue (Million US$),2018 – 2023
Figure 7 13: Natera – Overall NIPT Test Volume (Thousand), 2013 – 2017
Figure 7 14: Natera – Forecast for Overall NIPT Test Volume (Thousand), 2018 – 2023
Figure 7 15: Natera - Overall NIPT Test Market Revenue (Million US$),2013 – 2017
Figure 7 16: Natera – Forecast for Overall NIPT Test Market Revenue (Million US$),2018 – 2023